Alan Quintana, BA

  • 2Articles
  • 31.3KReads
  • 2023–2024Active
  • 5Collaborators
  • 1Citations

About

Alan Quintana, BA, is affiliated with First Choice Neurology in Miami, Florida. His publications in Psychiatrist.com from 2023 to 2024 focus on cognition and COVID-related topics, including the potential use of antidepressants for Long COVID and cognitive screening methods to detect early cognitive decline in diverse patient populations. He has frequently collaborated with Emma V. Rivas-Vazquez, Rafael A. Rivas-Vazquez, Enrique J. Carrazana, Gustavo Rey, and Luz Restrepo.

Publications

PCC
Potential Use of Antidepressants for Long COVID
Letter to the Editor

Potential Use of Antidepressants for Long COVID

May 16, 2024

The possibility of repurposing antidepressants as a potential treatment for long COVID first emerged following observations that antidepressants might reduce morbidity and mortality when administered during acute COVID.
, , , et al
PCC
Brief Cognitive Screener Detects Early Signs of Cognitive Decline in Anglo and Hispanic Patients
Brief Report

Brief Cognitive Screener Detects Early Signs of Cognitive Decline in Anglo and Hispanic Patients

December 12, 2023

The South Florida Cognitive Screener is an 8-item self-report instrument developed to capture the most common cognitive, functional, and behavioral complaints typically reported early in the process of cognitive...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe